Discovery of new gene called Brd2 that regulates obesity and diabetes

December 14, 2009

The chance discovery of a genetic mutation that makes mice enormously fat but protects them from diabetes has given researchers at Boston University School of Medicine, USA, new insights into the cellular mechanisms that link obesity to Type 2 diabetes. Dr Gerald Denis and his colleagues report their findings in the current issue of The Biochemical Journal.

The researchers were studying the gene, called Brd2, which had not previously been linked to body energy balance. While complete absence of the gene was fatal, Dr Denis found that in mice where there had been a single, genetic change in the Brd2 gene, fortuitously reducing its expression, the mice became severely obese - but did not go on to develop Type 2 diabetes. This result was very surprising because in both 'mice and men', chronic obesity commonly leads to Type 2 diabetes, with its life-threatening consequences, including heart disease, kidney and nerve damage, osteoporosis, blindness and circulation problems in the feet that can require amputation.

If the mice had been human their weight would be equivalent to approximately 270 kilograms (600 pounds); despite this, they exercised at the same levels as normal mice and, in comparison, lived for a surprisingly long time.

Obesity is linked to the development of Type 2 diabetes, and as obesity levels soar - it is predicted that there will be around 366 million diabetic individuals worldwide by 2030 - there is an urgent need for a much deeper biological understanding of the forces that link obesity and diabetes, in order to design new drugs and therapies for treatment.

However around 20 - 30% of the adult obese population remain relatively healthy despite their obesity. These are populations with a healthy metabolism but who are obese (MHO) while others are metabolically obese but are at a normal weight (MONW).

Dr Denis said, "Studies have shown that these individuals have a reduced 'inflammatory profile'. Inflammation caused by normal immune cells called macrophages leads to insulin resistance and Type 2 diabetes - this inflammation is typically seen in connection with obesity but it is the inflammation that is a trigger for diabetes, not the obesity itself. The mechanisms that explain this protection from diabetes are not well understood."

He went on to add, "Much like these protected obese humans, the Brd2-deficient mice have reduced inflammation of fat and never develop failure of the beta cells in the pancreas that is associated with Type 2 diabetes".

The researchers suggest several mechanisms by which the Brd2 gene mutation may protect against the development of diabetes.

These mice have impaired production of inflammation molecules that are normally seen in infections, but that also contribute to Type 2 diabetes. This impairment has the surprising benefit of protecting them from obesity-induced diabetes.

Commenting on the findings, Dr Denis said, "The strong influence of Brd2 levels on insulin production and action suggest that Brd2 is likely to be a promising target for diabetes treatment, but also imply that overactive Brd2 might cause diabetes. The ways in which Brd2 affects the immune system may also play a part in Type 1 diabetes, further studies to determine this are needed."
-end-
Further information available from Dianne Stilwell, e- mail diannestilwell@me.com; tel +44 (0)20 8977 6510; mob +44 (0)7957 200214

Notes for Editors

1. "Brd2 disruption in mice causes severe obesity without Type 2 diabetes" by Fangnian Wang, Hongsheng Liu, Wanda P. Blanton, Anna Belkina, Nathan K. LeBrasseur and Gerald V. Denis, will be published in The Biochemical Journal (2009) Vol 425, part 1, pp 71-83 at www.biochemj.org on 14 December 2009

2. Dr Gerald Denis is at the Cancer Research Center, Boston University School of Medicine, Room K520, 72 East Concord Street, Boston MA 02118, USA. He can be contacted through Gina DiGravio, Media Relations Manager at Boston University School of Medicine Tel + 1 617-638-8480, e-mail gina.digravio@bmc.org

3. Pictures to accompany the story are available from Dianne Stilwell or Gina DiGravio - contact details above; Picture caption as follows:

"Despite obesity, mice with the depleted Brd2 gene avoid Type 2 diabetes and several other life-threatening complications normally seen in human obesity. They may provide a model to discover the molecular pathways that could be used to protect obese humans."

4. This research was supported by a grant from the National Institutes of Health, specifically the National Institute of Diabetes, Digestive and Kidney Diseases.

5. The Biochemical Journal is published on behalf of the Biochemical Society by Portland Press Limited. Portland Press Limited is a not-for-profit publisher of journals, books and electronic resources in the cellular and molecular life sciences. It also delivers association management solutions for publishers, learned societies and membership-based organizations.

Boston University Medical Center

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.